Details for New Drug Application (NDA): 203696
✉ Email this page to a colleague
The generic ingredient in LUPANETA PACK is leuprolide acetate; norethindrone acetate. There are twenty-two drug master file entries for this compound. Additional details are available on the leuprolide acetate; norethindrone acetate profile page.
Summary for 203696
Tradename: | LUPANETA PACK |
Applicant: | Abbvie Endocrine |
Ingredient: | leuprolide acetate; norethindrone acetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | Strength | 3.75MG/VIAL,N/A;N/A,5MG | ||||
Approval Date: | Dec 14, 2012 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | Strength | 11.25MG/VIAL,N/A;N/A,5MG | ||||
Approval Date: | Dec 14, 2012 | TE: | RLD: | Yes |
Expired US Patents for NDA 203696
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-001 | Dec 14, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-002 | Dec 14, 2012 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription